BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CNOT3, KIAA0691, 4849, ENSG00000088038, O75175, NOT3H, NOT3, LENG2
10 results:

  • 1. Platinum-based chemotherapy for early triple-negative breast cancer.
    Mason SR; Willson ML; Egger SJ; Beith J; Dear RF; Goodwin A
    Cochrane Database Syst Rev; 2023 Sep; 9(9):CD014805. PubMed ID: 37681577
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
    Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
    Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Role of shear wave elastography as an adjunct to axillary ultrasonography in predicting nodal metastasis in breast cancer patients with suspicious nodes.
    Pulappadi VP; Paul S; Hari S; Dhamija E; Manchanda S; Kataria K; Mathur S; Mani K; Gogia A; Deo S
    Br J Radiol; 2022 Jun; 95(1134):20220055. PubMed ID: 35290097
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of genetic variants of FBXO32 and FOXO6 in the FOXO pathway with breast cancer risk.
    Wang H; Liu H; Zhao L; Luo S; Akinyemiju T; Hwang S; Yue Y; Wei Q
    Mol Carcinog; 2021 Oct; 60(10):661-670. PubMed ID: 34197655
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Opportunities for translational epidemiology: the important role of observational studies to advance precision oncology.
    Marrone M; Schilsky RL; Liu G; Khoury MJ; Freedman AN
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):484-9. PubMed ID: 25750251
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effects of different information brochures on women's decision-making regarding mammography screening: study protocol for a randomized controlled questionnaire study.
    Gummersbach E; in der Schmitten J; Abholz HH; Wegscheider K; Pentzek M
    Trials; 2013 Oct; 14():319. PubMed ID: 24083811
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical performance of 2 dedicated PET scanners for breast imaging: initial evaluation.
    Iima M; Nakamoto Y; Kanao S; Sugie T; Ueno T; Kawada M; Mikami Y; Toi M; Togashi K
    J Nucl Med; 2012 Oct; 53(10):1534-42. PubMed ID: 22933819
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging.
    Kuroki-Suzuki S; Kuroki Y; Nasu K; Nawano S; Moriyama N; Okazaki M
    Magn Reson Med Sci; 2007; 6(1):21-7. PubMed ID: 17510539
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. False-positive findings in mammography screening induces short-term distress - breast cancer-specific concern prevails longer.
    Aro AR; Pilvikki Absetz S; van Elderen TM; van der Ploeg E; van der Kamp LJ
    Eur J Cancer; 2000 Jun; 36(9):1089-97. PubMed ID: 10854941
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.
    Springer GF; Murthy SM; Desai PR; Fry WA; Tegtmeyer H; Scanlon EF
    Klin Wochenschr; 1982 Feb; 60(3):121-31. PubMed ID: 6176752
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.